gynecology drugs market
Pharmaceuticals

Global Gynecology Drugs Market Opportunities And Strategies 2023

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s gynecology drugs market report forecasts the gynecology drugs market size to grow to $36.23 Billion by 2027, with a CAGR (compound annual growth rate) of more than 6%.

Learn More On The Gynecology Drugs Market Report 2023 – https://www.thebusinessresearchcompany.com/report/gynecology-drugs-global-market-report

Gynecology Drugs Market Size Forecast
The global gynecology drugs market is expected to grow from $26.46 billion in 2022 to $28.09 billion in 2023 at a compound annual growth rate (CAGR) of 6.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The gynecology drugs market size is expected to grow to $36.23 billion in 2027 at a CAGR of 6.6%.

North America held the largest gynecology drugs market share, and Asia- was the fastest-growing region in 2022.

Key Gynecology Drugs Market Driver ­– Rise In The Number Of Women Suffering From Ovarian Cancer
For instance, according to Globocan, it is estimated that the global incidence of ovarian cancer will increase from 295,414 in 2018 to 434,184 by 2040. The increasing incidence of ovarian cancer would boost the market for gynecological drugs in the forecast period.

Request for A Sample Of The Global Gynecology Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4098&type=smp

Key Gynecology Drugs Market Trend – Developing Personalized Cancer Vaccines
Drug manufacturers are investing in developing personalized cancer vaccines, including gynecological cancers, and few have reached clinical trial phases. Pharmaceutical companies are combining genetic sequencing and precision medicine to create new drug therapies and cancer treatments that are designed to treat specific patients. Moderna announced the result of the ongoing Phase 1 clinical study in patients with both resected (adjuvant) and unresected (advanced) solid tumours. The results were positive when mRNA mRNA personalized cancer vaccine (PCV) mRNA-4157, was given alone or in combination with Merck pembrolizumab (KEYTRUDA®). Currently, the vaccine is in phase 2 clinical trial.

Gynecology Drugs Market Segment
1) By Therapeutics: Hormonal Therapy, Non-Hormonal Therapy
2) By Indication: Gynecology Cancers, Menopausal Disorder, Polycystic Ovary Syndrome, Contraception, Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Gynecology Drugs Market Major Players and Strategies
Major players in the gynecology drugs market are Hoffmann-La Roche Ltd., Pfizer Inc., Merck & Co. Inc., Allergan, AstraZeneca, Bayer AG, AbbVie, TherapeuticsMD Inc., Lupin Pharmaceuticals Inc., Ferring Holding SA, Johnson & Johnson, GlaxoSmithKline PLC., Eli Lilly and Company, Amgen Inc., and Sanofi.

In January 2020, India-based capital market company True North announced the acquisition of India-based Glenmark Pharmaceuticals Ltd gynecology business in India and Nepal for $16.2 million (INR 115 crore). Through this acquisition, True North aims to further grow the gynecology portfolio of Glenmark and expanding presence in multiple geographies.

The Gynecology Drugs Global Market Report 2023 covers regional data on gynecology drugs market size, gynecology drugs market trends and drivers, opportunities, strategies, and gynecology drugs market competitor analysis. The countries covered in the gynecology drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Gynecology drugs refer to a field of medicine that focuses on the treatment of illnesses of the female reproductive system, including care for women during pregnancy and childbirth. These drugs are used to treat gynecological diseases which include conditions and affecting the uterus, ovaries, and their appendages.

View More Reports Related To The Gynecology Drugs Market –
Gynecology Medical Lasers Global Market Report 2023
Drugs For Erectile Dysfunction Global Market Report 2023
Endoscopy Devices And Equipment Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas
+1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: